In mice, researchers observed a dramatic increase in the tumors’ expression of SOX17. This gene encodes a transcription factor that is normally active only during embryonic development. SoX17 prevents cells from synthesizing the receptor that normally detects interferon gamma. Without these receptors, cancerous and precancerous cells can simply ignore messages from the immune system.